Omega Announces Second Quarter 2009 Financial Results; Adjusted FFO of $0.37 Per Share for the Second Quarter
HUNT VALLEY, Md.--(BUSINESS WIRE)-- Omega Healthcare Investors, Inc. (NYSE:OHI) today announced its results of operations for the quarter ended June 30, 2009. The Company also reported Funds From Operations ("FFO") available to common stockholders for the three months ended June 30, 2009 of $28.6 million or $0.35 per common share. The $28.6 million of FFO available to common stockholders for the second quarter of 2009 includes a net loss of $1.1 million associated with owned and operated assets, a non-recurring, non-cash charge of approximately $0.5 million relating to the write-off of deferred financing costs associated with the replacement of the Company's old credit facility and $0.5 million of non-cash restricted stock expense. FFO is presented in accordance with the guidelines for the calculation and reporting of FFO issued by the National Association of Real Estate Investment Trusts ("NAREIT"). Adjusted FFO was $0.37 per common share for the three months ended June 30, 2009. FFO and Adjusted FFO are non-GAAP financial measures. Adjusted FFO excludes the impact of certain non-cash items and certain items of revenue or expenses, including: results of operations of owned and operated facilities during the period, the refinancing interest expense and restricted stock expense. For more information regarding FFO and Adjusted FFO, see the "Funds From Operations" section below.
GAAP NET INCOME
For the three-month period ended June 30, 2009, the Company reported net income of $19.8 million, net income available to common stockholders of $17.6 million, or $0.21 per diluted common share on operating revenues of $49.2 million. This compares to net income of $17.1 million, net income available to common stockholders of $14.6 million, or $0.20 per diluted common share on operating revenues of $43.7 million for the same period in 2008.
For the six-month period ended June 30, 2009, the Company reported net income of $44.7 million, net income available to common stockholders of $40.2 million, or $0.49 per diluted common share on operating revenues of $98.3 million. This compares to net income of $34.4 million, net income available to common stockholders of $29.4 million, or $0.41 per diluted common share on operating revenues of $84.6 million for the same period in 2008.
The year-to-date increases in net income and net income available to common stockholders were primarily due to the impact of: i) $4.0 million of net cash flow associated with legal settlements; ii) revenue associated with $60 million of new investments completed since June 2008; iii) a $1.9 million reduction in interest expense; and iv) a $4.3 million expense for uncollectible accounts receivable and a $1.5 million provision for impairment charge both recorded in 2008. This impact was partially offset by: i) increased depreciation expense associated with the new investments; ii) a $2.1 million net loss associated with owned and operated assets and iii) a $0.5 million charge relating to the write-off of deferred financing credit facility costs.
SECOND QUARTER 2009 RESULTS
Operating Revenues and Expenses - Operating revenues for the three months ended June 30, 2009, excluding nursing home revenues of owned and operated assets and therefore on a non-GAAP basis, were $44.8 million. Operating expenses for the three months ended June 30, 2009, on a non-GAAP basis excluding nursing home expenses for owned and operated assets, totaled $14.1 million, comprised of $11.0 million of depreciation and amortization expense, $2.6 million of general and administrative expenses and $0.5 million of restricted stock expense. A reconciliation of these amounts to revenues and expenses reported in accordance with GAAP is provided at the end of this release.
Other Income and Expense - Other income and expense for the three months ended June 30, 2009 was a net expense of $9.7 million and was primarily comprised of $8.7 million of interest expense, $0.5 million of amortization of deferred financing costs and $0.5 million related to the write-off of deferred financing credit facility costs.
Funds From Operations - For the three months ended June 30, 2009, reportable FFO available to common stockholders was $28.6 million, or $0.35 per common share on 82.7 million weighted-average common shares outstanding, compared to $24.4 million, or $0.33 per common share on 73.0 million weighted-average common shares outstanding, for the same period in 2008.
The $28.6 million of FFO for the quarter includes the impact of a $1.1 million net loss associated with owned and operated assets, $0.5 million of non-cash restricted stock expense and $0.5 million write-off of deferred financing credit facility costs (see "Financing Activities" section below). The $24.4 million of FFO for the three months ended June 30, 2008, includes the impact of: i) a $4.3 million non-cash expense for uncollectible accounts receivable; ii) $0.7 million one-time cash revenue; iii) $0.5 million of net cash proceeds received from a legal settlement; iv) $0.5 million of non-cash restricted stock expense; and v) $45,000 of non-cash FIN 46R consolidation adjustments required in 2008.
When excluding the above mentioned items in 2009 and 2008, Adjusted FFO was $30.7 million, or $0.37 per common share, for the three months ended June 30, 2009, compared to $27.9 million, or $0.38 per common share, for the same period in 2008. The Company had 9.6 million additional weighted-average shares for the three months ended June 30, 2009, compared to the same period in 2008. The increase in weighted-average common shares were primarily a result of: i) a 5.9 million common share offering on May 6, 2008; ii) a 6.0 million share common stock offering on September 19, 2008; and iii) approximately 1.3 million common shares issued under the Company's Dividend Reinvestment and Common Stock Purchase Plan. For further information, see the attached "Funds From Operations" schedule and notes.
New $200 Million Revolving Credit Facility - On June 30, 2009, the Company entered into a new $200 million revolving senior secured credit facility (the "New Credit Facility"). Banc of America Securities LLC and Deutsche Bank Trust Company Americas were joint lead arrangers for the New Credit Facility. Bank of America, N.A. was the administrative agent and UBS Securities LLC and General Electric Capital Corporation participated in the New Credit Facility in various agent capacities. The New Credit Facility will be used for acquisitions and general corporate purposes.
The New Credit Facility replaces the Company's previous senior secured credit facility (the "Prior Credit Facility"). The New Credit Facility matures in three years, on June 30, 2012, and includes an "accordion feature" that permits the Company to expand its borrowing capacity to $300 million in certain circumstances during the first two years thereof, and is currently priced at LIBOR plus 400 basis points with a 200 basis point LIBOR floor.
For the three-month period ended June 30, 2009, the Company recorded a non-recurring, non-cash charge of approximately $0.5 million relating to the write-off of deferred financing costs associated with the replacement of the Prior Credit Facility. At June 30, 2009, the Company had $46.0 million of borrowings outstanding under the New Credit Facility.
Equity Distribution Agreement - On June 12, 2009, the Company entered into separate Equity Distribution Agreements with each of UBS Securities LLC, Deutsche Bank Securities Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, each as sales agents and/or principal (the "Managers"). Under the terms of these agreements, the Company may sell shares of its common stock, from time to time, through or to the Managers having an aggregate gross sales price of up to $100,000,000. Sales of the shares, if any, will be made by means of ordinary brokers' transactions on the New York Stock Exchange at market prices, or as otherwise agreed with the applicable Manager. The Company will pay each Manager compensation for sales of the shares equal to 2% of the gross sales price per share of shares sold through such Manager, as sales agent, under the applicable agreement.
Common Dividends - On July 15, 2009, the Company's Board of Directors announced a common stock dividend of $0.30 per share to be paid August 17, 2009 to common stockholders of record on July 31, 2009. At the date of this release, the Company had approximately 83.3 million outstanding common shares.
Series D Preferred Dividends - On July 15, 2009, the Company's Board of Directors declared the regular quarterly dividends for the Company's 8.375% Series D Cumulative Redeemable Preferred Stock ("Series D Preferred Stock") to stockholders of record on July 31, 2009. The stockholders of record of the Series D Preferred Stock on July 31, 2009 will be paid dividends in the amount of $0.52344 per preferred share on August 17, 2009. The liquidation preference for the Company's Series D Preferred Stock is $25.00 per share. Regular quarterly preferred dividends for the Series D Preferred Stock represent dividends for the period May 1, 2009 through July 31, 2009.
Dividend Reinvestment and Common Stock Purchase Plan - On April 29, 2009, the Company announced the reinstatement of the optional cash purchase component of the Dividend Reinvestment and Common Stock Purchase Plan, effective immediately for investments beginning May 15, 2009. Existing participants in the Plan have been sent a letter from the Company discussing enrollment status and procedures. All questions and requests in connection with the Plan should be directed to the Plan's administrator, Computershare, at (800) 519-3111.
2009 ADJUSTED FFO GUIDANCE AFFIRMATION
The Company affirmed its 2009 Adjusted FFO available to common stockholders guidance of between $1.47 and $1.50 per diluted share, as previously announced on February 6, 2009.
The Company's Adjusted FFO guidance for 2009 excludes the impacts of future acquisitions, gains and losses from the sale of assets, additional divestitures, certain revenue and expense items, capital transactions and restricted stock amortization expense. A reconciliation of the Adjusted FFO guidance to the Company's projected GAAP earnings is provided on a schedule attached to this press release. The Company may, from time to time, update its publicly announced Adjusted FFO guidance, but it is not obligated to do so.
The Company's Adjusted FFO guidance is based on a number of assumptions, which are subject to change and many of which are outside the control of the Company. If actual results vary from these assumptions, the Company's expectations may change. Without limiting the generality of the foregoing, the completion of acquisitions, divestitures, capital and financing transactions, variations in restricted stock amortization expense, and the factors identified below may cause actual results to vary materially from our current expectations. There can be no assurance that the Company will achieve its projected results.
The Company will be conducting a conference call on Thursday, July 30, 2009, at 10 a.m. EDT to review the Company's 2009 second quarter results and current developments. To listen to the conference call via webcast, log on to www.omegahealthcare.com and click the "earnings call" icon on the Company's home page. Webcast replays of the call will be available on the Company's website for two weeks following the call.
The Company is a real estate investment trust investing in and providing financing to the long-term care industry. At June 30, 2009, the Company owned or held mortgages on 254 SNFs and assisted living facilities with approximately 29,148 licensed beds (27,642 available beds) located in 28 states and operated by 25 third-party healthcare operating companies.
This announcement includes forward-looking statements, including without limitation the information under the heading "2009 Adjusted FFO Guidance Affirmation." Actual results may differ materially from those reflected in such forward-looking statements as a result of a variety of factors, including, among other things: (i) uncertainties relating to the business operations of the operators of the Company's properties, including those relating to reimbursement by third-party payors, regulatory matters and occupancy levels; (ii) regulatory and other changes in the healthcare sector, including without limitation, changes in Medicare reimbursement; (iii) changes in the financial position of the Company's operators; (iv) the ability of operators in bankruptcy to reject unexpired lease obligations, modify the terms of the Company's mortgages, and impede the ability of the Company to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor's obligations; (v) the availability and cost of capital; (vi) the Company's ability to maintain its credit ratings; (vii) competition in the financing of healthcare facilities; (viii) the Company's ability to maintain its status as a real estate investment trust; (ix) the Company's ability to manage, re-lease or sell any owned and operated facilities; (x) the Company's ability to sell closed or foreclosed assets on a timely basis and on terms that allow the Company to realize the carrying value of these assets; (xi) the effect of economic and market conditions generally, and particularly in the healthcare finance industry; (xii) the potential impact of a general economic slowdown on governmental budgets and healthcare reimbursement expenditures; and (xiii) other factors identified in the Company's filings with the Securities and Exchange Commission. Statements regarding future events and developments and the Company's future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements. The Company undertakes no obligation to update any forward-looking statements contained in this material.
OMEGA HEALTHCARE INVESTORS, INC. CONSOLIDATED BALANCE SHEETS (in thousands) June 30, December 31, 2009 2008 (Unaudited) ASSETS Real estate properties Land and buildings $ 1,378,811 $ 1,372,012 Less accumulated depreciation (273,721 ) (251,854 ) Real estate properties - net 1,105,090 1,120,158 Mortgage notes receivable - net 100,630 100,821 1,205,720 1,220,979 Other investments - net 29,744 29,864 1,235,464 1,250,843 Assets held for sale - net 687 150 Total investments 1,236,151 1,250,993 Cash and cash equivalents 4,923 209 Restricted cash 6,602 6,294 Accounts receivable - net 79,228 75,037 Other assets 12,886 18,613 Operating assets for owned and operated properties 4,060 13,321 Total assets $ 1,343,850 $ 1,364,467 LIABILITIES AND STOCKHOLDERS' EQUITY Revolving line of credit $ 46,000 $ 63,500 Unsecured borrowings - net 484,689 484,697 Accrued expenses and other liabilities 24,691 25,420 Operating liabilities for owned and operated 2,066 2,862 properties Total liabilities 557,446 576,479 Stockholders' equity: Preferred stock issued and outstanding - 4,340 shares Series D with an aggregate liquidation 108,488 108,488 preference of $108,488 Common stock $.10 par value authorized - 200,000 shares: issued and outstanding - 82,872 shares as 8,287 8,238 of June 30, 2009 and 82,382 as of December 31, 2008 Common stock - additional paid-in-capital 1,061,869 1,054,157 Cumulative net earnings 485,011 440,277 Cumulative dividends paid (877,251 ) (823,172 ) Total stockholders' equity 786,404 787,988 Total liabilities and stockholders' equity $ 1,343,850 $ 1,364,467
OMEGA HEALTHCARE INVESTORS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS Unaudited (in thousands, except per share amounts) Three Months Ended Six Months Ended June 30, June 30, 2009 2008 2009 2008 Revenues Rental income $ 41,225 $ 39,774 $ 82,400 $ 77,787 Mortgage interest income 2,895 2,550 5,771 3,529 Other investment income - net 539 582 1,150 1,218 Miscellaneous 130 829 204 2,067 Nursing home revenues of owned 4,363 - 8,787 - and operated assets Total operating revenues 49,152 43,735 98,312 84,601 Expenses Depreciation and amortization 10,990 9,713 21,921 19,109 General and administrative 2,607 2,446 5,286 5,014 Restricted stock expense 479 525 959 1,051 Impairment loss on real estate - - 70 1,514 properties Provision for uncollectible - 4,268 - 4,268 accounts receivable Nursing home expenses of owned 5,498 - 10,851 - and operated assets Total operating expenses 19,574 16,952 39,087 30,956 Income before other income and 29,578 26,783 59,225 53,645 expense Other income (expense): Interest and other investment 6 58 17 123 income Interest (8,712 ) (9,745 ) (17,485 ) (19,430 ) Interest - amortization of (500 ) (500 ) (1,000 ) (1,000 ) deferred financing costs Interest - refinancing costs (526 ) - (526 ) - Litigation settlements - 526 4,527 526 Total other expense (9,732 ) (9,661 ) (14,467 ) (19,781 ) Income before (loss) gain on 19,846 17,122 44,758 33,864 assets sold (Loss) gain on assets sold - (24 ) - (24 ) 46 net Income from continuing 19,822 17,122 44,734 33,910 operations Discontinued operations - - - 446 Net income 19,822 17,122 44,734 34,356 Preferred stock dividends (2,272 ) (2,481 ) (4,543 ) (4,962 ) Net income available to common $ 17,550 $ 14,641 $ 40,191 $ 29,394 stockholders Income per common share available to common stockholders: Basic: Income from continuing $ 0.21 $ 0.20 $ 0.49 $ 0.41 operations Net income $ 0.21 $ 0.20 $ 0.49 $ 0.42 Diluted: Income from continuing $ 0.21 $ 0.20 $ 0.49 $ 0.41 operations Net income $ 0.21 $ 0.20 $ 0.49 $ 0.41 Dividends declared and paid $ 0.30 $ 0.30 $ 0.60 $ 0.59 per common share Weighted-average shares 82,573 72,942 82,485 70,811 outstanding, basic Weighted-average shares 82,674 73,038 82,578 70,893 outstanding, diluted Components of other comprehensive income: Net income $ 19,822 $ 17,122 $ 44,734 $ 34,356 Total comprehensive income $ 19,822 $ 17,122 $ 44,734 $ 34,356
OMEGA HEALTHCARE INVESTORS, INC. FUNDS FROM OPERATIONS Unaudited (In thousands, except per share amounts) Three Months Ended Six Months Ended June 30, June 30, 2009 2008 2009 2008 Net income available to common $ 17,550 $ 14,641 $ 40,191 $ 29,394 stockholders Add back loss (deduct gain) from 24 -- 24 (477 ) real estate dispositions(1) Sub-total 17,574 14,641 40,215 28,917 Elimination of non-cash items included in net income: Depreciation and amortization(1) 10,990 9,713 21,921 19,109 Funds from operations available $ 28,564 $ 24,354 $ 62,136 $ 48,026 to common stockholders Weighted-average common shares 82,573 72,942 82,485 70,811 outstanding, basic Effect of restricted stock awards 90 84 80 70 Assumed exercise of stock options 11 12 11 12 Deferred stock -- -- 2 -- Weighted-average common shares 82,674 73,038 82,578 70,893 outstanding, diluted Fund from operations per share $ 0.35 $ 0.33 $ 0.75 $ 0.68 available to common stockholders Adjusted funds from operations: Funds from operations available $ 28,564 $ 24,354 $ 62,136 $ 48,026 to common stockholders Deduct litigation settlements -- (526 ) (4,527 ) (526 ) Deduct one-time cash revenue -- (702 ) -- (702 ) Deduct FIN 46R adjustment -- (45 ) -- (90 ) Deduct collection prior operator's past due rental -- -- -- (650 ) obligation Deduct nursing home revenues (4,363 ) -- (8,787 ) -- Add back non-cash provision for -- 3,784 -- 3,784 uncollectible accounts receivable Add back non-cash provision for uncollectible accounts receivable -- 484 -- 484 - FIN 46R related Add back non-cash provision for impairments on real estate -- -- 70 1,514 properties(1) Add back nursing home expenses 5,498 -- 10,851 -- Add back one-time interest 526 -- 526 -- refinancing expense Add back non-cash restricted 479 525 959 1,051 stock expense Adjusted funds from operations $ 30,704 $ 27,874 $ 61,228 $ 52,891 available to common stockholders
(1) Includes amounts in discontinued operations
This press release includes Funds From Operations, or FFO, which is a non-GAAP financial measure. For purposes of the Securities and Exchange Commission's Regulation G, a non-GAAP financial measure is a numerical measure of a company's historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable financial measure calculated and presented in accordance with GAAP in the statement of operations, balance sheet or statement of cash flows (or equivalent statements) of the company, or includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable financial measure so calculated and presented. As used in this press release, GAAP refers to generally accepted accounting principles in the United States of America. Pursuant to the requirements of Regulation G, the Company has provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.
The Company calculates and reports FFO in accordance with the definition and interpretive guidelines issued by the National Association of Real Estate Investment Trusts ("NAREIT"), and consequently, FFO is defined as net income available to common stockholders, adjusted for the effects of asset dispositions and certain non-cash items, primarily depreciation and amortization. The Company believes that FFO is an important supplemental measure of its operating performance. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time, while real estate values instead have historically risen or fallen with market conditions. The term FFO was designed by the real estate industry to address this issue. FFO herein is not necessarily comparable to FFO of other real estate investment trusts, or REITs, that do not use the same definition or implementation guidelines or interpret the standards differently from the Company.
In February 2004, NAREIT informed its member companies that it was adopting the position of the SEC with respect to asset impairment charges and would no longer recommend that impairment write-downs be excluded from FFO. In the tables included in this press release, the Company has applied this interpretation and has not excluded asset impairment charges in calculating its FFO. As a result, its FFO may not be comparable to similar measures reported in previous disclosures. According to NAREIT, there is inconsistency among NAREIT member companies as to the adoption of this interpretation of FFO. Therefore, a comparison of the Company's FFO results to another company's FFO results may not be meaningful.
The Company uses FFO as one of several criteria to measure the operating performance of its business. The Company further believes that by excluding the effect of depreciation, amortization and gains or losses from sales of real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, FFO can facilitate comparisons of operating performance between periods and between other REITs. The Company offers this measure to assist the users of its financial statements in analyzing its performance; however, this is not a measure of financial performance under GAAP and should not be considered a measure of liquidity, an alternative to net income or an indicator of any other performance measure determined in accordance with GAAP. Investors and potential investors in the Company's securities should not rely on this measure as a substitute for any GAAP measure, including net income.
Adjusted FFO is calculated as FFO available to common stockholders less non-cash stock-based compensation and one-time revenue and expense items. The Company believes that Adjusted FFO provides an enhanced measure of the operating performance of the Company's core portfolio as a REIT. The Company's computation of Adjusted FFO is not comparable to the NAREIT definition of FFO or to similar measures reported by other REITs, but the Company believes it is an appropriate measure for this Company.
The following table presents a reconciliation of our guidance regarding 2009 FFO and Adjusted FFO to net income available to common stockholders:
2009 Projected Per diluted share: Net income available to common stockholders $ 0.94 $ 0.97 Adjustments: Depreciation and amortization 0.53 0.53 Funds from operations available to common stockholders $ 1.47 $ 1.50 Adjustments: Legal settlement income (0.05 ) (0.05 ) Nursing home revenue and expense - net 0.02 0.02 Interest expense - refinancing 0.01 0.01 Impairment on real estate assets 0.00 0.00 Restricted stock expense 0.02 0.02 Adjusted funds from operations available to common $ 1.47 $ 1.50 stockholders
The following table summarizes the results of discontinued operations for assets held for sale and facilities sold during the three and six months ended June 30, 2009 and 2008, respectively.
Three Months Ended Six Months Ended June 30, June 30, 2009 2008 2009 2008 (in thousands) Revenues Rental income $ -- $ -- $ -- $ 15 Expenses -- -- -- -- Income before gain on sale of assets -- -- -- 15 Gain on assets sold - net -- -- -- 431 Discontinued operations $ -- $ -- $ -- $ 446
The table below reconciles reported revenues and expenses to revenues and expenses excluding nursing home revenues and expenses of owned and operated assets:
Three Months Ended Six Months Ended June 30, June 30, 2009 2008 2009 2008 (in thousands) Total operating revenues $ 49,152 $ 43,735 $ 98,312 $ 84,601 Nursing home revenues of owned and 4,363 -- 8,787 -- operated assets Revenues excluding nursing home revenues $ 44,789 $ 43,735 $ 89,525 $ 84,601 of owned and operated assets Total operating expenses $ 19,574 $ 16,952 $ 39,087 $ 30,956 Nursing home expenses of owned and 5,498 -- 10,851 -- operated assets Expenses excluding nursing home expenses $ 14,076 $ 16,952 $ 28,236 $ 30,956 of owned and operated assets
This press release includes references to revenues and expenses excluding nursing home and operated assets, which are non-GAAP financial measures. The Company believes that presentation of the Company's revenues and expenses, excluding nursing home owned and operated assets, provides a useful measure of the operating performance of the Company's core portfolio as a real estate investment trust in view of the disposition of all but two of the Company's owned and operated assets and short term holding of owned and operated assets. The table below reconciles reported revenues and expenses to revenues and expenses excluding nursing home revenues and expenses of owned and operated assets.
The following tables present selected portfolio information, including operator and geographic concentrations, and revenue maturities for the period ending June 30, 2009:
Portfolio Composition ($000's) Balance # of # of Sheet Data Properties Licensed Investment % Investment Beds Real Property(1) 239 25,802 $ 1,398,011 93 % (3) Loans Receivable 15 1,840 100,630 7 % (2) Total 254 27,642 $ 1,498,641 100 % Investments Investment # of # of Investment per Data Properties Licensed Investment % Investment Bed Beds Skilled Nursing 243 27,027 $ 1,438,950 96 % $ 53 Facilities (1) (2) (3) Assisted Living 7 383 29,854 2 % 78 Facilities Rehab 4 232 29,837 2 % 129 Hospitals 254 27,642 $ 1,498,641 100 % $ 54 (1) Includes $19.2 million for lease inducement. (2) Includes $1.0 million of unamortized principal. (3) Excludes one facility classified as held for sale.
Revenue Composition ($000's) Revenue by Investment Type(1) Three Months Ended Six Months Ended June 30, 2009 June 30, 2009 Rental Property $ 41,225 92 % $ 82,400 92 % Mortgage Notes 2,895 7 % 5,771 7 % Other Investment Income 539 1 % 1,150 1 % $ 44,659 100 % $ 89,321 100 % Revenue by Facility Type(1) Three Months Ended Six Months Ended June 30, 2009 June 30, 2009 Skilled Nursing Facilities $ 43,216 97 % $ 86,360 97 % Assisted Living Facilities 599 1 % 1,200 1 % Specialty Hospitals 305 1 % 611 1 % Other 539 1 % 1,150 1 % $ 44,659 100 % $ 89,321 100 % (1) Excludes revenue from owned and operated assets.
Operator Concentration ($000's) Concentration by Investment # of Properties Investment % Investment CommuniCare Health Services 36 $ 317,835 21 % Sun Healthcare Group, Inc. 40 212,584 14 % Advocat Inc. 40 149,309 10 % Guardian LTC Management (1) 23 145,171 10 % Signature Holdings, LLC 18 142,460 10 % Formation Capital 14 119,469 8 % Nexion Health, Inc. 19 79,951 5 % Essex Healthcare Corp. 13 79,564 5 % Alpha Healthcare Properties, LLC 8 55,834 4 % Mark Ide Limited Liability Company 10 36,264 2 % Remaining Operators (2) (3) 33 160,200 11 % 254 $ 1,498,641 100 % (1) Investment amount includes a $19.2 million lease inducement. (2) Includes $1.0 million of unamortized principal. (3) Excludes one facility classified as held for sale.
Concentration by State # of Properties Investment % Investment Ohio 47 $ 333,985 22 % Florida (2) 25 173,086 11 % Pennsylvania 23 150,225 10 % Texas 20 83,973 6 % West Virginia (1) 10 73,930 5 % Maryland 7 69,928 5 % Louisiana 14 55,343 4 % Colorado 8 53,828 3 % Arkansas 11 44,791 3 % Alabama 10 44,068 3 % Rhode Island 4 39,668 3 % Massachusetts 6 39,089 3 % Kentucky 10 36,966 2 % California 11 34,756 2 % Connecticut 4 30,582 2 % Remaining States (3) 44 234,423 16 % 254 $ 1,498,641 100 % (1) Investment amount includes a $19.2 million lease inducement. (2) Includes $1.0 million of unamortized principal. (3) Excludes one facility classified as held for sale.
Revenue Maturities ($000's) Operating Lease Current Lease Current Interest Lease and Expirations Year Revenue (1) Revenue (1) Interest % & Loan Revenue Maturities 2009 - - - 0 % 2010 496 1,431 1,927 1 % 2011 4,598 68 4,666 3 % 2012 3,175 - 3,175 2 % 2013 24,717 - 24,717 14 % Thereafter 126,253 9,887 136,140 80 % $ 159,239 $ 11,386 $ 170,625 100 % (1) Based on 2009 contractual rents and interest (assumes no annual escalators). Selected Facility Data TTM ending Coverage Data 3/31/09 % Revenue Mix Before After Census (1) Private Medicare Mgmt. Fees Mgmt. Fees Total 85.4 % 9.3 % 25.4 % 2.0 x 1.6 x Portfolio
(1) Based on available beds.
The following table presents a debt maturity schedule for the period ending June 30, 2009:
Debt Maturities ($000's) Secured Debt Year Lines of Senior Notes Total Credit (1) 2009 $ - $ - $ - 2010 - - - 2011 - - - 2012 200,000 - 200,000 2013 - - - Thereafter - 485,000 485,000 $ 200,000 $ 485,000 $ 685,000 (1) Reflected at 100% borrowing capacity.
The following table presents investment activity for the three- and six- month periods ending June 30, 2009:
Investment Activity ($000's) Three Months Ended Six Months Ended June 30, 2009 June 30, 2009 $ Amount % $ Amount % Funding by Investment Type: Real Property $ - 0 % $ - 0 % Mortgages - 0 % - 0 % Other 3,693 100 % 6,675 100 % Total $ 3,693 100 % $ 6,675 100 %
Source: Omega Healthcare Investors, Inc.
Released July 30, 2009